Wei H, Frenkel K
Department of Environmental Medicine, New York University Medical Center, New York 10016-6451.
Cancer Res. 1991 Aug 15;51(16):4443-9.
There has been a paucity of evidence showing that 12-O-tetradecanoyl-phorbol-13-acetate (TPA), a potent tumor promoter, causes DNA damage in vivo. We show that oxidized DNA bases are formed in the epidermis of TPA-treated SENCAR mice in a dose- and time-dependent manner. As measured by high-performance liquid chromatography and acetylation of nucleosides with [3H]acetic anhydride, these oxidized DNA derivatives include cis-thymidine glycol, 5-hydroxymethyl-2'-deoxyuridine, and 8-hydroxyl-2'-deoxyguanosine. Their maximal formation induced by a single TPA dose occurred within 6-8 h (a 2-5-fold increase). The level of 8-hydroxyl-2'-deoxyguanosine was the lowest (3.2/10(5) bases) and remained almost unchanged for 18 h; thymidine glycol (29.1/10(4) bases) and 5-hydroxymethyl-2'-deoxyuridine (17.3/10(4) bases) declined gradually but were still above controls at 24 h. Reapplication of TPA 20 h after the first dose (time of the maximal polymorphonuclear leukocyte infiltration) enhanced the net formation of 8-hydroxyl-2'-deoxyguanosine by 3.8-fold (P less than 0.05), of cis-thymidine glycol by 1.9-fold (P less than 0.001), and of 5-hydroxymethyl-2'-deoxyuridine by 2.0-fold (P less than 0.01), as compared to those maximally produced by a single TPA dose. Thus, the infiltration of polymorphonuclear leukocytes into TPA-treated mouse skin, which was corroborated by histological examination and the presence of polymorphonuclear leukocyte-specific myeloperoxidase, might play an important role in TPA-induced DNA oxidation in vivo. Our findings provide proof that tumor promoters can induce genetic modification in vivo that is oxidative in nature. Hence, formation of oxidized DNA bases may be responsible for the genetic effects of tumor promoters in carcinogenesis.
目前缺乏证据表明强效肿瘤促进剂12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)在体内会导致DNA损伤。我们发现,经TPA处理的SENCAR小鼠表皮中会以剂量和时间依赖的方式形成氧化的DNA碱基。通过高效液相色谱以及用[³H]乙酸酐对核苷进行乙酰化测定,这些氧化的DNA衍生物包括顺式胸腺嘧啶二醇、5 - 羟甲基 - 2'- 脱氧尿苷和8 - 羟基 - 2'- 脱氧鸟苷。单次TPA剂量诱导它们的最大生成量在6 - 8小时内出现(增加2 - 5倍)。8 - 羟基 - 2'- 脱氧鸟苷的水平最低(3.2 / 10⁵个碱基),并且在18小时内几乎保持不变;胸腺嘧啶二醇(29.1 / 10⁴个碱基)和5 - 羟甲基 - 2'- 脱氧尿苷(17.3 / 10⁴个碱基)逐渐下降,但在24小时时仍高于对照组。在首次给药20小时后(多形核白细胞浸润达到最大值的时间)重新施用TPA,与单次TPA剂量产生的最大值相比,8 - 羟基 - 2'- 脱氧鸟苷的净生成量增加了3.8倍(P < 0.05),顺式胸腺嘧啶二醇增加了1.9倍(P < 0.001),5 - 羟甲基 - 2'- 脱氧尿苷增加了2.0倍(P < 0.01)。因此,组织学检查以及多形核白细胞特异性髓过氧化物酶的存在证实了多形核白细胞浸润到经TPA处理的小鼠皮肤中,这可能在TPA诱导的体内DNA氧化中起重要作用。我们的研究结果证明肿瘤促进剂可在体内诱导本质上为氧化性的基因修饰。因此,氧化的DNA碱基的形成可能是肿瘤促进剂在致癌过程中产生遗传效应的原因。